Navigation Links
B-Phycoerythrin Labeling Kit-NH2 from Abnova Corporation

ProductsB-Phycoerythrin Labeling Kit-NH2 from Abnova Corporation
Company Abnova Corporation
Item B-Phycoerythrin Labeling Kit-NH2
Price 
Description B-Phycoerythrin Labeling Kit - NH2 is primarily used for the preparation of B-phycoerythrin-labeled antibody for immunostaining and cellular proteins for tracing. NH2-Reactive B-Phycoerythrin, a component of this kit, has succinimidyl group (NHS), and can easily make a covalent bond with amino groups of IgG or other proteins without any activation process. Filtration Tube included in this kit is used for removing small molecules in the sample protein such as Tris buffer and amine compounds that interfere with the assay or labeling reaction. The maximum excitation and emission wavelengths of the B-phycoerythrin-labeled proteins are 564 nm and 575 nm, respectively. This kit contains all of the necessary reagents for labeling, including the storage buffer for conjugates.
Info Abnova CorporationAbnova Corporation
Abnova Corporation (HQ)
9th Fl., No. 108, Jhouzih St.
Neihu District, Taipei
114 Taiwan R.O.C.
Tel: +886-2-8751-1888
Fax: +886-2-8751-1166

Abnova GmbH
Boxbergring 107
69126 Heidelberg
Germany
Tel: +49 6221 3632226
Fax: +49 6221 825878

Customer Service: +886-2-8751-1888
Fax Number: +886-2-8751-1166
Web Site: http://www.abnova.com.tw
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Label IT siRNA Tracker Intracellular Localization Kit with TransIT-TKO Transfection Reagent (Cy5 Labeling Kit) from Mirus Bio Corporation
2. ELF® 97 Cytological Labeling Kit from CHEMICON
3. BioPrime Array CGH Genomic Labeling System from Invitrogen
4. BioPrime Plus Array CGH Indirect Genomic Labeling Module from Invitrogen
5. ULS cDNA Synthesis and Labeling Kit (with Cy3 and Cy5) from KREATECH Biotechnology
6. ULS cDNA Synthesis and Labeling Kit (with Biotin) from KREATECH Biotechnology
7. Uniform 13C, 15N, Labeling of Peptides and Proteins new from rPeptide, LLC
8. Genome-pULSe ULS arrayCGH Whole Genome Amplification and Labeling Kit (with REPLI-g and Cy3-ULS / Cy5-ULS from KREATECH Biotechnology
9. Acridinium Labeling Buffer from Cayman Chemical
10. BioPrime Array CGH Genomic Labeling Module from Invitrogen
11. SuperScript Indirect cDNA Labeling System from Invitrogen
Rabbit polyclonal to GPCR G2A ( Abpromise for all tested applications). entrezGeneID: 29933 SwissProtID: Q9UNW8...
... has been developed for use with ... of nonspecific background staining due to ... blocking peroxidase with hydrogen peroxide. ... combination with additional novel components to ...
Rabbit polyclonal to Wilms Tumor Protein ( Abpromise for all tested applications). entrezGeneID: 7490 SwissProtID: P19544...
Ku80 Antibody Shipping Temperature: HOT Storage Temperature: -20C...
Biology Products:
(Date:2/8/2017)... -- Report Highlights The global biosurgery market ... in 2016 at a compound annual growth rate (CAGR) ... - An overview of the global market for biosurgery. ... 2015 and 2016, and projections of compound annual growth ... on the basis of product type, source, application, and ...
(Date:2/3/2017)... 3, 2017  Texas Biomedical Research Institute announced that its ... Schlesinger as the Institute,s new President and CEO. Dr. ... 31, 2017. He is currently the Chair of the Department ... for Microbial Interface Biology at Ohio State University. ... President and CEO of Texas Biomed," said Dr. James ...
(Date:2/1/2017)... Massachusetts , February 1, 2017 IDTechEx ... events on emerging technology, announces the availability of a new report, ... Continue Reading ... ... in industrial and collaborative robots. Source: IDTechEx Report "Sensors for Robotics: ...
Breaking Biology News(10 mins):
(Date:2/16/2017)... and GREENWICH, Conn. , Feb. ... firm focused on venture growth investments in biotechnology ... Josh Richardson , M.D. to Managing Director. ... biotechnology companies.  He is a board observer at ... in Longitude,s investments in Aimmune Therapeutics, Akebia Therapeutics, ...
(Date:2/16/2017)... CALABASAS, Calif. , Feb. 16, 2017 /PRNewswire/ ... on developing groundbreaking therapies to treat severe neurological ... in children treated with AGT-181, the company,s investigational ... syndrome (also known as mucopolysaccharidosis type I, or ... Phase 2 proof-of-concept (POC) study, presented today at ...
(Date:2/16/2017)... 2017   Capricor Therapeutics, Inc. (NASDAQ: ... developing first-in-class biological therapies for cardiac and other ... to terminate its license agreement with the Mayo ... Cenderitide. "Our decision to return these ... our efforts to advance our core cell and ...
(Date:2/16/2017)... , February 16, 2017 ... infusion of innovative telemedicine application, new and leading ... are experiencing a boom worldwide. The healthcare sector ... of technologies, services and new therapies for companies ... (TSX-V: RHT), Cellectar Biosciences, Inc. (NASDAQ: ...
Breaking Biology Technology: